The B-cell system of human mucosae and exocrine glands

Immunological Reviews

Volumn 171, Issue , 1999, Pages 45-87

  Brandtzaeg, Per ^a   Farstad, Inger Nina ^a   Johansen, Finn Eirik ^a   Morton, H Craig ^a   Norderhaug, Inger Natvig ^a   Yamanaka, Takeshi ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN RECEPTOR; SECRETORY COMPONENT;

B LYMPHOCYTE; EXOCRINE GLAND; HUMAN; LYMPHOCYTE CLONE; MUCOSAL IMMUNITY; PRIORITY JOURNAL; REVIEW;

ANIMALS; B-LYMPHOCYTES; CELL MOVEMENT; EPITHELIUM; EXOCRINE GLANDS; HUMANS; IMMUNITY, MUCOSAL; INTESTINES; LYMPHOID TISSUE;

EID: 0032743853     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01342.x     Document Type: Review

References (350)

1. 1. Hanson LÅ, Brandtzaeg P. The discovery of secretory IgA and the mucosal immune system. Immunol Today 1993;14:416-417.
2. 2. Tomasi TB, Tan EM, Solomon A, Prendergast RA. Characteristics of an immune system common to certain external secretions. J Exp Med 1965;121:101-124.
3. 3. South MA, Cooper MD, Wollheim FA, Hong R, Good RA. The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med 1966;123:615-627.
4. 4. Crabbé PA, Carbonara AO, Heremans JF. The normal human intestinal mucosa as a major source of plasma cells containing. A-immunoglobulin. Lab Invest 1965;14:235-248.
5. 5. Brandtzaeg P, Baklien K. Immunohistochemical studies of the formation and epithelial transport of immunoglobulins in normal and diseased human intestinal mucosa. Scand J Gastroenterol 1976;11 (Suppl 36): 1-45.
6. 6. Brandtzaeg P. Two types of IgA immunocytes in man. Nature 1973;243:142-143.
7. 7. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Immunoglobulin M; local synthesis and selective secretion in patients with immunoglobulin A deficiency. Science 1968;160:789-791.
8. 8. Brandtzaeg P. Human secretory immunoglobulin M. An immunochemical and immunohistochemical study. Immunology 1975;29:559-570.
9. 9. Brown WR, Isobe Y, Nakane PK. Studies on translocation of immunoglobulins across intestinal epithelium. II. Immunoelectron-microscopic localization of immunoglobulins and secretory component in human intestinal mucosa. Gastroenterology 1976;71:985-995.
10. 10. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Differential localization of free and bound SC in secretory epithelial cells. J Immunol 1974;112:1553-1559.
11. 11. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology 1974;26:1101-1114.
12. 12. Halpern MS, Koshland ME. Novel subunit in secretory IgA. Nature 1970;228:1276-1278.
13. 13. Mestecky J, Zikan J, Butler W. Immunoglobulin M and secretory immunoglobulin A: evidence for a common polypeptide chain different from light chains. Science 1971;171:1163-1165.
14. 14. Bastian A, Kratzin H, Eckart K, Hilschmann N. Intra-and interchain disulfide bridges of the human J chain in secretory immunoglobulin A. Biol Chem Hoppe Seyler 1992;373:1255-1263.
15. 15. Brandtzaeg P, Prydz H. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature 1984;311:71-73.
16. 16. Vaerman J-P et al. Antibody against the human J chain inhibits polymeric Ig receptor-mediated biliary and epithelial transport of human polymeric IgA. Eur J Immunol 1998;28:171-182.
17. 17. Vaerman JP, Langendries A, Giffroy D, Brandtzaeg P, Kobayashi K. Lack of SC/pIgR-mediated epithelial transport of a human polymeric IgA devoid of J chain: in vitro and in vivo studies. Immunology 1998;95:90-96.
18. 18. Johansen F-E, Norderhaug IN, Roe M, Sandlie I, Brandtzaeg P. Recombinant expression of polymeric IgA: incorporation of J chain and secretory component of human origin. Eur J Immunol 1999;29:1701-1708.
19. 19. Brandtzaeg P. Presence of J chain in human immunocytes containing various immunoglobulin classes. Nature 1974;252:418-420.
20. 20. Brandtzaeg P. Immunohistochemical characterization of intracellular J-chain and binding site for secretory component (SC) in human immunoglobulin (Ig) producing cells. Mol Immunol 1983;20:941-966.
21. 21. Castrignano SB, Carlsson B, Carneiro-Sampaio MS, Soderstrom T, Hanson LA. IgA and IgG subclass deficiency in a poor population in a developing country. Scand J Immunol 1993;37:509-514.
22. 22. Brandtzaeg P, Nilssen DE. Mucosal aspects of primary B-cell deficiency and gastrointestinal infections. Curr Opin Gastroenterol 1995;11:532-540.
23. 23. Cunningham-Rundles C. Disorders of the IgA system. In: Stiehm ER, eds. Immunologic disorders in infants and children. 4th ed. London: Saunders; 1996. p. 423-442.
24. 24. McLoughlin GA, Hede JE, Temple JG, Bradley J, Chapman DM, McFarland J. The role of IgA in the prevention of bacterial colonization of the jejunum in the vagotomized subject. Br J Surg 1978;65:435-437.
25. 25. Brandtzaeg P, Gjeruldsen ST, Korsrud F, Baklien K, Berdal P, Ek J. The human secretory immune system shows striking heterogeneity with regard to involvement of J chain positive IgD immunocytes. J Immunol 1979;122:503-510.
26. 26. Cataldo F, Marino V, Ventura A, Bottaro G, Corazza GR. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut 1998;42:362-365.
27. 27. Brandtzaeg P, Baklien K, Bjerke K, Rognum TO, Scott H, Valnes K. Nature and properties of the human gastrointestinal immune system. In: Miller K, Nicklin S, eds. Immunology of the gastrointestinal tract. Vol I. Boca Raton, Florida: CRC Press; 1987. p. 1-85.
28. 28. Brandtzaeg P. Immune responses to gut virus infections. In: Farthing MJG, ed. Viruses and the gut. London: Smith Kline, French Laboratories Ltd; 1989. p. 45-54.
29. 29. Johansen F E, et al. Absence of epithelial IgA transport, with increased mucosal leakiness, in pIgR/SC-deficient mice. J Exp Med (In press).
30. 30. Brandtzaeg P, et al. Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 1999;20:141-151.
31. 31. Langman JM, Rowland R. The number and distribution of lymphoid follicles in the human large intestine. J Anat 1986;149:189-194.
32. 32. Goldblum RM, Hanson LÅ, Brandtzaeg P. The mucosal defense system. In: Stiehm ER, ed. Immunologic disorders in infants and children. 4th ed. Philadelphia: WB Saunders; 1996. p. 159-199.
33. 33. Brandtzaeg P, Farstad IN, Haraldsen G. Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol Today 1999;20:267-277.
34. 34. Hanson LÅ, et al. Child health and the population increase. Peace, Health and Development 1993;4:31-38.
35. 35. Anonymous. A warm chain for breastfeeding. Lancet 1994;344:1239-1241.
36. 36. Wright AL, Bauer M, Naylor A, Sutcliffe E, Clark L. Increasing breastfeeding rates to reduce infant illness at the community level. Pediatrics 1998;101:837-844.
37. 37. Saarinen UM, Kajosaari M. Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old. Lancet 1995;346:1065-1069.
38. 38. Brandtzaeg P. Development of the intestinal immune system and its relation to coeliac disease. In: Mäki M, Collin P, Visakorpi JK, eds. Coeliac disease. Proceedings of the Seventh International Symposium on Coeliac Disease. Tampere: Coeliac Disease Study Group; 1997, p. 221-244.
39. 39. Dickinson EC, et al. Immunoglobulin A supplementation abrogates bacterial translocation and preserves the architecture of the intestinal epithelium. Surgery 1998;124:284-290.
40. 40. Berneman A, Belec L, Fischetti VA, Bouvet JP. The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions. Infect Immun 1998;66:4163-4168 .
41. 41. Persson CG, et al. Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways. Scand J Immunol 1998;47:302-313.
42. 42. Mbawuike IN, Pacheco S, Acuna CL, Switzer KC, Zhang Y, Harriman GR. Mucosal immunity to influenza without IgA: An IgA knockout mouse model. J Immunol 1999;162:2530-2537.
43. 43. Brandtzaeg P. Mucosal immunity in the female genital tract. J Reprod Immunol 1997;36:23-50.
44. 44. Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME. A three-tiered view of the role of IgA in mucosal defense. Immunol Today 1993;14:430-435.
45. 45. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996;272:104-107.
46. 46. Bomsel M, et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 1998;9:277-287.
47. 47. Fujioka H, et al. Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium. J Exp Med 1998;188:1223-1229.
48. 48. Mowat AM, Viney JL. The anatomical basis of intestinal immunity. Immunol Rev 1997;156:145-166.
49. 49. Christ AD, Blumberg RS. The intestinal epithelial cell: immunological aspects. Springer Semin Immunopathol 1997;18:449-461.
50. 50. Brandtzaeg P. History of oral tolerance and mucosal immunity. Ann N Y Acad Sci 1996;778:1-27.
51. 51. Strobel S, Mowat AM. Immune responses to dietary antigens: oral tolerance. Immunol Today 1998;19:173-181.
52. 52. Rugtveit J, Bakka A, Brandtzaeg P. Differential distribution of B7.1 (CD80) and B7.2 (CD86) co-stimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin Exp Immunol 1997;110:104-113.
53. 53. Viney JL, Mowat AM, O'Malley JM, Williamson E, Fanger NA. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol 1998;160:5815-525.
54. 54. Gütgemann I, Fahrer AM, Altman JD, Davis MM, Chien YH. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 1998;8:667-673.
55. 55. Sallusto F, Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 1999;189:611-614.
56. 56. Scott H, et al. Immunopathology of gluten-sensitive enteropathy. Springer Semin Immunopathol 1997;18:535-553.
57. 57. Brandtzaeg P, Haraldsen G, Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol 1997;18:555-589.
58. 58. Rubin W, Fauci AS, Sleisenger MH, Jeffries GH. Immunofluorescent studies in adult celiac disease. J Clin Invest 1965;44:475-485.
59. 59. Van der Heijden PJ, Stok W, Bianchi AT. Contribution of immunoglobulin-secreting cells in the murine small intestine to the total 'background' immunoglobulin production. Immunology 1987;62:551-555.
60. 60. Brandtzaeg P, et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989;97:1562-1584.
61. 61. Turesson I. Distribution of immunoglobulin-containing cells in human bone marrow and lymphoid tissues. Acta Med Scand 1976;199:293-304.
62. 62. Tseng J. Expression of immunoglobulin isotypes by lymphoid cells of mouse intestinal lamina propria. Cell Immunol 1982;73:324-336.
63. 63. Liu Y-J, Banchereau J. The paths and molecular controls of peripheral B-cell development. Immunologist 1996;4:55-66.
64. 64. Fossum S, Rolstad B, Tjernshaugen H. Selective loss of S-phase cells when making cell suspensions from lymphoid tissue. Cell Immunol 1979;48:149-154.
65. 65. Mayrhofer G. Physiology of the intestinal immune system. In: Newby TJ, Stokes CR, eds. Local immune responses of the gut. Boca Raton, Florida: CRC Press; 1984. p. 1-96.
66. 66. Farstad IN, Halstensen TS, Lazarovits AI, Norstein J, Fausa O, Brandtzaeg P. Human intestinal B-cell blasts and plasma cells express the mucosal homing receptor integrin α4β7. Scand J Immunol 1995;42:662-672.
67. 67. Bienenstock J, Befus D, McDermott M, Mirski S, Rosenthal K. Regulation of lymphoblast traffic and localization in mucosal tissues, with emphasis on IgA. Fed Proc 1983;42:3213-3217.
68. 68. Husband AJ. Kinetics of extravasation and redistribution of IgA-specific antibody-containing cells in the intestine. J Immunol 1982;128:1355-1359.
69. 69. Baklien K, Brandtzaeg P, Fausa O. Immunoglobulins in jejunal mucosa and serum from patients with adult coeliac disease. Scand J Gastroenterol 1977;12:149-159.
70. 70. André C, André F, Fargier MC. Distribution of IgA1 and IgA2 plasma cells in various normal human tissues and in the jejunum of plasma IgA-deficient patients. Clin Exp Immunol 1978;33:327-231.
71. 71. Crago SS, et al. Distribution of IgAI-, IgA2-, and J chain-containing cells in human tissues. J Immunol 1984;132:16-18.
72. 72. Jonard PP, Rambaud JC, Dive C, Vaerman JP, Galian A, Delacroix DL. Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest 1984;74:525-535.
73. 73. Kett K, Brandtzaeg P, Radl J, Haaijman JJ. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol 1986;136:3631-3635.
74. 74. Burnett D, Crocker J, Stockley RA. Cells containing IgA subclasses in bronchi of subjects with and without chronic obstructive lung disease. Clin Pathol 1987;40:1217-1220.
75. 75. Müller F, Frøland SS, Hvatum M, Radl J, Brandtzaeg P. Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol 1991;83:203-209.
76. 76. Felielius N, Hvatum M, Brandtzaeg P, Knutson L, Hällgren R. Increased jejunal secretory IgA and IgM in ankylosing spondylitis: normalization after treatment with sulfasalazine. J Rheumatol 1994;21:2076-2081.
77. 77. Brandtzaeg P. Human secretory component. VI. Immunoglobulin-binding properties. Immunochemistry 1977;14:179-188.
78. 78. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 1996;104:321-338.
79. 79. Mestecky J, Russell MW. IgA subclasses. Monogr Allergy 1986;19:277-301.
80. 80. Tarkowski A, Lue C, Moldoveanu Z, Kiyono H, McGhee JR, Mestecky J. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J Immunol 1990;144:3770-3778.
81. 81. Kett K, Baklien K, Bakken A, Kral JG, Fausa O, Brandtzaeg P. Intestinal B-cell isotype response in relation to local bacterial load: evidence for immunoglobulin A subclass adaptation. Gastroenterology 1995;109:819-825.
82. 82. Brandtzaeg P, Karlsson G, Hansson G, Petruson B, Björkander J, Hanson LÅ. The clinical condition of IgA deficient patients is related to the proportion of IgD-and IgM-producing cells in their nasal mucosa. Clin Exp Immunol 1987;67:626-636.
83. 83. Valnes K, Brandtzaeg P, Elgjo K, Stave R. Quantitative distribution of immunoglobulin-producing cells in gastric mucosa: relation to chronic gastritis and glandular atrophy. Gut 1986;27:505-514.
84. 84. Korsrud FR, Brandtzaeg P. Quantitative immuno histochemistry of immunoglobulin-and J-chain-producing cells in human parotid and submandibular glands. Immunology 1980;39:129-140.
85. 85. Brandtzaeg P. Mechanisms of gastrointestinal reactions to food. Environ Toxicol Pharmacol 1997;4:9-24.
86. 86. Bjerke K, Brandtzaeg P. Terminally differentiated human intestinal B cells. IgA and IgG subclass-producing immunocytes in the distal ileum, including Peyer's patches, compared with lymph nodes and palatine tonsils. Scand J Immunol 1990;32:61-67.
87. 87. Nilssen DE, et al. Isotype distribution of mucosal IgG-producing cells in patients with various IgG subclass deficiencies. Clin Exp Immunol 1991;83:17-24.
88. 88. Helgeland L, et al. The IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease. Gut 1992;33:1358-1364.
89. 89. Flanagan JG, Rabbitts TH. Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing γ, ε and α genes. Nature 1982;300:709-713.
90. 90. Papadea C, Check IJ. Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects. Crit Rev Clin Lab Sci 1989;27:27-58.
91. 91. Takahashi T, et al. The joining (J) chain is present in invertebrates that do not express immunoglobulins. Proc Natl Acad Sci USA 1996;93:1886-1891.
92. 92. Eskeland T, Brandtzaeg P. Does J chain mediate the combination of 19S IgM and dimeric IgA with the secretory component rather than being necessary for their polymerization? Immunochemistry 1974;11:161-163.
93. 93. Brandtzaeg P. Complex formation between secretory component and human immunoglobulins related to their content of J chain. Scand J Immunol 1976;5:411-419.
94. 94. Brandtzaeg P. Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man. Scand J Immunol 1985;22:111-146.
95. 95. Hendrickson BA, et al. Lack of association of secretory component with IgA in J chain-deficient mice. J Immunol 1996;157:750-754.
96. 96. Ma JK, et al. Generation and assembly of secretory antibodies in plants. Science 1995;268:716-719.
97. 97. Brewer JW, Randall TD, Parkhouse RM, Corley RB. IgM hexamers? Immunol Today 1994;15:165-168.
98. 98. Wiersma EJ, Collins C, Fazel S, Shulman MJ. Structural and functional analysis of J chain-deficient IgM. J Immunol 1998;160:5979-5989.
99. 414 and the secretory tailpiece. J Immunol 1999;162:3448-3455.
100. 100. Brandtzaeg P, Korsrud FR. Significance of different J chain profiles in human tissues: generation of IgA and IgM with binding site for secretory component is related to the J chain expressing capacity of the total local immunocyte population, including IgG and IgD producing cells, and depends on the clinical state of the tissue. Clin Exp Immunol 1984;58:709-718.
101. 101. Stott SI. Biosynthesis and assembly of IgM, Addition of J-chain to intracellular pools of 8S and 19S IgM. Immunochemistry 1976;13:157-163.
102. 102. Brewer JW, Corley RB. Late events in assembly determine the polymeric structure and biological activity of secretory IgM. Mol Immunol 1997;34:323-331.
103. 103. Parkhouse RMF, Della Corte E. Control of IgA biosynthesis. In: Beers RF, Bassett EG, eds. The role of immunological factors in infections, allergic, and autoimmune processes. New York: Raven Press; 1976. p. 389-401.
104. 104. Roth R, Mather EL, Koshland ME. Intracellular events in the differentiation of B lymphocytes to pentamer IgM synthesis. In: Pernis B, Vogel HJ, eds. Cells of immunoglobulin synthesis. London: Academic Press; 1979. p. 141-151.
105. 105. Kett K, Brandtzaeg P, Fausa O. J-chain expression is more prominent in immunoglobulin A2 than in immunoglobulin A1 colonic immunocytes and is decreased in both subclasses associated with inflammatory bowel disease. Gastroenterology 1988;94:1419-1425.
106. 106. Bull DM, Bienenstock J, Tomasi TB. Studies on human intestinal immunoglobulin A. Gastroenterology 1971;60:370-380.
107. 107. MacDermott RP, et al. Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease. Gastroenterology 1986;91:379-385.
108. 108. Kutteh WH, Koopman WJ, Conley ME, Egan ML, Mestecky J. Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens. J Exp Med 1980;152:1424-1429.
109. 109. Moldoveanu Z, Egan ML, Mestecky J. Cellular origins of human polymeric and monomeric IgA: intracellular and secreted forms of IgA. J Immunol 1984;133:3156-3162.
110. 110. Nagura H, Brandtzaeg P, Nakane PK, Brown WR. Ultrastructural localization of J chain in human intestinal mucosa. J Immunol 1979;123:1044-1050.
111. 111. Moro I, Iwase T, Komiyama K, Moldoveanu Z, Mestecky J. Immunoglobulin A (IgA) polymerization sites in human immunocytes: immunoelectron microscopic study. Cell Struct Funct 1990;15:85-91.
112. 112. Della Corte E, Parkhouse RME. Biosynthesis of immunoglobulin A (IgA) and immunoglobulin M (IgM). Requirement for J-chain and a disulphide exchange enzyme for polymerization. Biochem J 1973;136:597-606.
113. 113. Mestecky J, Winchester RJ, Hoffman T, Kunkel HG. Parallel synthesis of immunoglobulins and J chain in pokeweed mitogen-stimulated normal cells and in lymphoblastoid cell lines. J Exp Med 1977;145:760-765.
114. 114. Roth RA, Koshland ME. Identification of a lymphocyte enzyme that catalyzes pentamer immunoglobulin M assembly. J Biol Chem 1981;256:4633-4639.
115. 115. Delamette F, Marty MC, Panijel J. In vitro study of IgM polymerization. Cell Immunol 1975;19:262-275.
116. 116. Meng YG, Criss AB, Georgiadis KE. J chain deficiency in human IgM monoclonal antibodies produced by Epstein-Barr virus-transformed B lymphocytes. Eur J Immunol 1990;20:2505-2508.
117. 117. Bjerke K, Brandtzaeg P. Terminally differentiated human intestinal B cells. J chain expression of IgA and IgG subclass-producing immunocytes in the distal ileum compared with mesenteric and peripheral lymph nodes. Clin Exp Immunol 1990;82:411-415.
118. 118. Nilssen DE, Brandtzaeg P, Froland SS, Fausa O. Subclass composition and J-chain expression of the "compensatory" gastrointestinal IgG cell population in selective IgA deficiency. Clin Exp Immunol 1992;87:237-245.
119. 119. Mosmann TR, Gravel Y, Williamson AR, Baumal R. Modification and fate of J chain in myeloma cells in the presence and absence of immunoglobulin secretion. Eur J Immunol 1978;8:94-101.
120. 120. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996;272:54-60.
121. 121. Bjerke K, Brandtzaeg P. Immunoglobulin-and J-chain-producing cells associated with the lymphoid follicles of human appendix, colon and ileum, including the Peyer's patches. Clin Exp Immunol 1986;64:432-441.
122. 122. Bjerke K, Brandtzaeg P, Rognum TO. Distribution of immunoglobulin producing cells is different in normal human appendix and colon mucosa. Gut 1986;27:667-664.
123. 123. Korsrud FR, Brandtzaeg P. Immunohistochemical evaluation of J-chain expression by intra-and extra follicular immunoglobulin-producing human tonsillar cells. Scand J Immunol 1981;13:271-280.
124. 124. Brandtzaeg P. Immune functions and immunopathology of palatine and nasopharyngeal tonsils. In: Bernstein JM, Ogra PL, eds. Immunology of the ear. New York: Raven Press; 1987. p. 63-106.
125. 125. Koshland ME. The coming of age of the immunoglobulin J chain. Annu Rev Immunol 1985;3:425-453.
126. 126. Rinkenberger JL, Wallin JJ, Johnson KW, Koshland ME. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity 1996;5:377-386.
127. 127. Shin MK, Koshland ME. Ets related protein PU. 1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element. Genes Dev 1993;7:2006-2015.
128. 128. Rao S, Karray S, Gackstetter ER, Koshland ME. Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter. J Biol Chem 1998;273:26123-26129.
129. 129. Turner CA, Mack DH, Davis MM. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 1994;77:297-306.
130. 130. Takayasu H, Brooks KH. IL-2 and IL-5 both induce μ, and J chain mRNA in a clonal B cell line, but differ in their cell-cycle dependency for optimal signaling. Cell Immunol 1991;136:472-485.
131. 131. Randall TD, Parkhouse RM, Corley RB. J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5. Proc Natl Acad Sci USA 1992;89:962-966.
132. 132. Tigges MÁ, Casey LS, Koshland ME. Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway. Science 1989;243:781-786.
133. 133. Kang CJ, Sheridan C, Koshland ME. A stage specific enhancer of immunoglobulin J chain gene is induced by interleukin-2 in a presecretor B cell stage. Immunity 1998;8:285-295.
134. 134. McCune JM, Fu SM, Kunkel HG. J chain biosynthesis in pre-B cells and other possible precursor B cells. J Exp Med 1981;154:138-145.
135. 135. Hadju I, Moldoveanu Z, Cooper M, Mestecky J. Ultrastructural studies of human lymphoid cells. p and J chain expression as a function of B cell differentiation. J Exp Med 1983;158:1993-2006.
136. 136. Max EE, Korsmeyer SJ. Human J chain gene. Structure and expression in B lymphoid cells. J Exp Med 1985;161:832-849.
137. 137. Kubagawa H, Burrows PD, Grossi CE, Mestecky J, Cooper MD. Precursor B cells transformed by Epstein-Barr virus undergo sterile plasma-cell differentiation: J-chain expression without immunoglobulin. Proc Natl Acad Sci USA 1988;85:875-879.
138. 138. Iwase T, et al. Early expression of human J chain and μ chain gene in the fetal liver. Cell Struct Funct 1993;18:297-302.
139. 139. Bertrand FE, Billips LG, Gartland GL, Kubagawa H, Schroeder HW. The J chain gene is transcribed during B and T lymphopoiesis in humans. J Immunol 1996;156:4240-4244.
140. 140. Savidge TC. The life and times of an intestinal M cell. Trends Microbiol 1996;4:301-306.
141. 141. Brandtzaeg P. Immunological functions of adenoids. In: van Cauwenberge P, Wang D-Y, Ingels K, Bachert C, eds. The nose. The Hague: Kugler Publications; 1998. p. 233-246.
142. 142. Brandtzaeg P. Regionalized immune function of tonsils and adenoids. Immunol Today 1999;20:383-384.
143. 143. Brandtzaeg P, Nilssen DE, Rognum TO, Thrane PS. Ontogeny of the mucosal immune system and IgA deficiency. Gastroenterol Clin North Am 1991;20:397-439.
144. 144. Kapasi ZF, et al. Follicular dendritic cell (FDC) precursors in primary lymphoid tissues. J Immunol 1998;160:1078-1084.
145. 145. Tarlinton D. Germinal centers: form and function. Curr Opin Immunol 1998;10:245-251.
146. 146. Chaplin DD, Fu Y. Cytokine regulation of secondary lymphoid organ development. Curr Opin Immunol 1998;10:289-297.
147. 147. Fu YX, Huang G, Wang Y, Chaplin DD. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α dependent fashion. J Exp Med 1998;187:1009-1018.
148. 148. Liu Y-J, de Bouteiller O, Fugier Vivier I. Mechanisms of selection and differentiation in germinal centers. Curr Opin Immunol 1997;9:256-262.
149. 149. MacLennan ICM. Germinal centers. Annu Rev Immunol 1994;12:117-139.
150. 150. Liu Y-J, Arpin C. Germinal center development. Immunol Rev 1997;156:111-126.
151. 151. MacLennan IC, et al. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol Rev 1997;156:53-66.
152. 152. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998;281:96-99.
153. 153. Lindhout E, Koopman G, Pals ST, de Groot C. Triple check for antigen specificity of B cells during germinal centre reactions. Immunol Today 1997;18:573-577.
154. 154. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 1998;95:10089-10093.
155. 155. Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996;87:1037-1047.
156. 156. Goodnow CC, Cyster JG. Lymphocyte homing: the scent of a follicle. Curr Biol 1997;7:R219-R222.
157. 157. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998;391:799-803.
158. 158. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998;187:655-660.
159. 159. Bleul CC, Schultze JL, Springer TA. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med 1998;187:753-762.
160. 160. Szabo MC, Butcher EC, McEvoy LM. Specialization of mucosal follicular dendritic cells revealed by mucosal addressin-cell adhesion molecule-1 display. J Immunol 1997;158:5584-5588.
161. 161. Brandtzaeg P, Halstensen TS. Immunology and immunopathology of tonsils. Adv Otorhinolaryngol 1992;47:64-75.
162. 162. Lampert IA, Schofield JB, Amlot P, Van Noorden S. Protection of germinal centres from complement attack: decay-accelerating factor (DAF) is a constitutive protein on follicular dendritic cells. A study in reactive and neoplastic follicles. J Pathol 1993;170:115-120.
163. 163. Pulendran B, van Driel R, Nossal GJ. Immunological tolerance in germinal centres. Immunol Today 1997;18:27-32.
164. 164. Cleary AM, Fortune SM, Yellin MJ, Chess L, Lederman S. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. J Immunol 1995;155:3329-3337.
165. 165. Koopman G, Keehnen RM, Lindhout E, Zhou DF, de Groot C, Pals ST. Germinal center B cells rescued from apoptosis by CD40 ligation or attachment to follicular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD95-induced apoptosis. Eur J Immunol 1997;27:1-7.
166. 166. Grouard G, Durand I, Filgueira L, Banchereau J, Liu YJ. Dendritic cells capable of stimulating T cells in germinal centres. Nature 1996;384:364-367.
167. 167. Randall TD, Heath AW, Santos-Argumedo L, Howard MC, Weissman IL, Lund FE. Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity 1998;8:733-742.
168. 168. Arpin C, Banchereau J, Liu YJ. Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J Exp Med 1997;186:931-940.
169. 169. Ngo VN, Tang HL, Cyster JG. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 1998;188:181-191.
170. 170. Liu YJ, Barthélémy C, de Bouteiller O, Arpin C, Durand I, Banchereau J. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 1995;2:239-248.
171. 171. Slifka MK, Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998;10:252-258.
172. 172. Strober W, Sneller MC. Cellular and molecular events accompanying IgA B cell differentiation. Monogr Allergy 1988;24:181-190.
173. 173. Conley ME, Bartelt MS. In vitro regulation of IgA subclass synthesis. II. The source of IgA2 plasma cells. J Immunol 1984;133:2312-2316.
174. 174. Zan H, Cerutti A, Dramitinos P, Schaffer A, Casali P. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-β: evidence for TGF-β but not IL-10-dependent direct Sμ→Sα and sequential Sμ→Sγ, Sγ→Sα DNA recombination. J Immunol 1998;161:5217-5225.
175. 175. Arpin C, et al. The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cμ Cδ switch, and λ light chain expression. J Exp Med 1998;187:1169-1178.
176. +) homes to regional effector sites but not to the gut [Abstract]. Scand J Immunol 1998;47:620.
177. 177. Ruan MR, Akkoyunlu M, Grubb A, Forsgren A. Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD. J Immunol 1990;145:3379-3384.
178. 178. Janson H, Heden LO, Grubb A, Ruan MR, Forsgren A. Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli. Infect Immun 1991;59:119-125.
179. 179. Parkhouse RME, Cooper MD. A model for the differentiation of B lymphocytes with implications for the biological role of IgD. Immunol Rev 1977;37:105-126.
180. 180. Schrader CE, George A, Kerlin RL, Cebra JJ. Dendritic cells support production of IgA and other non-IgM isotypes in clonal microculture. Int Immunol 1990;2:563-570.
181. 181. Fayette J, et al. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J Exp Med 1997;185:1909-1918.
182. 182. Brandtzaeg P. Molecular and cellular aspects of the secretory immunoglobulin system. APMIS 1995;103:1-19.
183. 183. Nilsen EM, Lundin KEA, Krajči P, Scott H, Sollid LM, Brandtzaeg P. Gluten-specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon γ. Gut 1995;37:766-776.
184. 184. Fujihashi K, et al. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J Clin Invest 1991;88:248-252.
185. 185. Brière F, et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994;94:97-104.
186. 186. Defrance T, Vanbervliet B, Briers F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992;175:671-682.
187. 187. Kimata H, Fujimoto M. Induction of IgA1 and IgA2 production in immature human fetal B cells and pre-B cells by vasoactive intestinal peptide. Blood 1995;85:2098-2104.
188. 188. Boirivant M, Fais S, Annibale B, Agostini D, Delle Fave G, Pallone F. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology 1994;106:576-582.
189. 189. Pascual DW, Xu-Amano JC, Kiyono H, McGhee JR, Bost KL. Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production. J Immunol 1991;146:2130-2136.
190. 190. Fujihashi, et al. γ/δ T cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med 1996;183:1929-1935.
191. 191. Jahnsen FL, Farstad IN, Aanesen JP, Brandtzaeg P. Phenotypic distribution of T cells in human nasal mucosa differs from that in the gut. Am J Respir Cell Molec Biol 1998;18:392-401.
192. 192. Kett K, Scott H, Fausa O, Brandtzaeg P. Secretory immunity in celiac disease: cellular expression of immunoglobulin A subclass and joining chain. Gastroenterology 1990;99:386-392.
193. 193. Watanabe M, et al. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest 1995;95:2945-2953.
194. 194. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-66.
195. 195. Briskin M, et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997;151:97-110.
196. 196. Streeter PR, Berg EL, Rouse BT, Bargatze RF, Butcher EC. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 1988;331:41-46.
197. 197. Shyjan AM, Bertagnolli M, Kenney CJ, Briskin MJ. Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) demonstrates structural and functional similarities to the α4β7-integrin binding domains of murine MAdCAM-1, but extreme divergence of mucin-like sequences. J Immunol 1996;156:2851-2857.
198. 198. Denis V, et al. Selective induction of peripheral and mucosal endothelial cell addressins with peripheral lymph nodes and Peyer's patch cell-conditioned media. J Leukoc Biol 1996;60:744-752.
199. 199. Berg EL, McEvoy LM, Berlin C, Bargatze RF, Butcher EC. L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 1993;366:695-698.
200. 200. Berlin C, et al. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995;80:413-422.
201. 201. Pachynski RK, Wu SW, Gunn MD, Erle DJ. Secondary lymphoid-tissue chemokine (SLC) stimulates integrin α4β7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow. J Immunol 1998;161:952-956.
202. 202. Farstad IN, Halstensen TS, Lien B, Kilshaw PJ, Lazarovits AI, Brandtzaeg P. Distribution of β7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology 1996;89:227-237.
203. 203. Farstad IN, Halstensen TS, Kvale D, Fausa O, Brandtzaeg P. Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue. Relation of L-selectin and integrin α4β7 to naive and memory phenotypes. Am J Pathol 1997;150:187-199.
204. 204. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-568.
205. 205. Del Pozo MA, Sánchez-Mateos P, Sánchez-Madrid F. Cellular polarization induced by chemokines: a mechanism for leucocyte recruitment? Immunol Today 1996;17:127-131.
206. 206. Nakano H, et al. Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes. Eur J Immunol 1997;27:215-221.
207. 207. Gunn MD, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999;189:451-460.
208. 208. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998;279:381-384.
209. 209. Middleton J, et al. Transcytosis and surface presentation of IL 8 by venular endothelial cells. Cell 1997;91:385-395.
210. 210. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 1998;95:258-263.
211. 211. Campbell JJ, et al. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J Cell Biol 1998;141:1053-1059.
212. 212. Willimann K, et al. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol 1998;28:2025-2034.
213. 213. Postigo AA, Sanchez-Mateos P, Lazarovits AI, Sanchez-Madrid F, de Landazuri MO. α4β7 integrin mediates B cell binding to fibronectin and vascular cell adhesion molecule-1: expression and function of α4 integrins on human B lymphocytes. J Immunol 1993;151:2471-2483.
214. 214. Ohtsuka A, Piazza AJ, Ermak TH, Owen RL. Correlation of extracellular matrix components with the cytoarchitecture of mouse Peyer's patches. Cell Tissue Res 1992;269:403-410.
215. 215. Gretz JE, Anderson AO, Shaw S. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol Rev 1997;156:11-24.
216. 216. Bianchi E, Bender JR, Blasi F, Pardi R. Through and beyond the wall: late steps in leukocyte transendothelial migration. Immunol Today 1997;18:586-591.
217. 217. Farstad IN, Norstein J, Brandtzaeg P. Phenotypes of B and T cells in human intestinal and mesenteric lymph. Gastroenterology 1997;112:163-173.
218. 218. Fujisaka M, Ohtani O, Watanabe Y. Distribution of lymphatics in human palatine tonsils: a study by enzyme-histochemistry and scanning electron microscopy of lymphatic corrosion casts. Arch Histol Cytol 1996;59:273-280.
219. 219. Hub E, Rot A. Binding of RANTES, MCP-1, MCP-3, and MIP-1α to cells in human skin. Am J Pathol 1998;152:749-757.
220. 220. Bradley LM, Watson SR. Lymphocyte migration into tissue: the paradigm derived from CD4 subsets. Curr Opin Immunol 1996;8:312-320.
221. 221. Rott LS, Briskin MJ, Andrew DP, Berg EL, Butcher EC. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with β7 integrins and memory differentiation. J Immunol 1996;156:3727-3736.
222. 222. Guy-Grand D, Griscelli C, Vassalli P. The gut-associated lymphoid system: nature and properties of the large dividing cells. Eur J Immunol 1974;4:435-443.
223. 223. Parrott DM. The gut as a lymphoid organ. Clin Gastroenterol 1976;5:211-228.
224. 224. Bos NA, et al. Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria. Infect Immun 1996;64:616-623.
225. 225. Dunn-Walters DK, Boursier L, Spencer J. Hypermutation, diversity and dissemination of human intestinal lamina propria plasma cells. Eur J Immunol 1997;27:2959-2964.
226. H region genes. Eur J Immunol 1998;28:2971-2977.
227. 227. Dunn-Walters DK, Isaacson PG, Spencer J. Sequence analysis of human IgVH genes indicates that ileal lamina propria plasma cells are derived from Peyer's patches. Eur J Immunol 1997;27:463-467.
228. 228. Lue C, et al. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin Exp Immunol 1994;96:356-363.
229. 229. Quiding-Järbrink M, et al. Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur J Immunol 1995;25:322-327.
230. 230. Quiding-Järbrink M, et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 1997;99:1281-1286
231. 231. Kantele A, et al. Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody secreting cells that all bear homing receptors directing them to the gut. J Immunol 1997;158:574-579.
232. 232. Halstead TE, Hall JG. The homing of lymph-borne immunoblasts to the small gut of neonatal rats. Transplantation 1972;14:339-346.
233. 233. Parrott DM, Ferguson A. Selective migration of lymphocytes within the mouse small intestine. Immunology 1974;26:571-588.
234. 234. Bode U, Wonigeit K, Pabst R, Westermann J. The fate of activated T cells migrating through the body: rescue from apoptosis in the tissue of origin. Eur J Immunol 1997;27:2087-2093.
235. 235. Janeway CA, et al. Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunol Today 1984;5:99-105.
236. 236. Thrane PS, Sollid LM, Haanes HR, Brandtzaeg P. Clustering of IgA-producing immunocytes related to HLA-DR-positive ducts in normal and inflamed salivary glands. Scand J Immunol 1992;35:43-51.
237. 237. Newman RA, Ormerod MG, Greaves MF. The presence of HLA-DR antigens on lactating human breast epithelium and milk fat globule membranes. Clin Exp Immunol 1980;41:478-486.
238. 238. Brandtzaeg P. The secretory immune system of lactating human mammary glands compared with other exocrine organs. Ann N Y Acad Sci 1983;409:353-381.
239. 239. Eerola E, Jalkanen S, Granfors K, Toivanen A. Immune capacity of the chicken bursectomized at 60 h of incubation. Effect of bursal epithelial cells and bursal epithelium-conditioned medium on the production of immunoglobulins and specific antibodies in vitro. Scand J Immunol 1984;19:493-500.
240. 240. Kremmidiotis G, Zola H. Changes in CD44 expression during B cell differentiation in the human tonsil. Cell Immunol 1995;161:147-157.
241. + tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J Exp Med 1996;183:227-236.
242. 242. Husband AJ, Monié HJ, Gowans JL. The natural history of cells producing IgA in the gut. Ciba Found Symp 1977;46:29-42.
243. 243. Lange S, Nygren H, Svennerholm A-M, Holmgren J. Antitoxic cholera immunity in mice: influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of the intestine. Infect Immun 1980;28:17-23.
244. 244. Pierce NF, Gowans JL. Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J Exp Med 1975;142:1550-1563.
245. 245. Ogra PL, Karzon DT. The role of immunoglobulins in the mechanism of mucosal immunity to virus infection. Pediatr Clin North Am 1970;17:385-400.
246. 246. Hopkins S, et al. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 1995;63:3279-3286.
247. 247. Kantele A, et al. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun 1998;66:5630-5635.
248. 248. Eriksson K. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect Immun 1998;66:5889-5896.
249. 249. Mizoguchi A, Mizoguchi E, Chiba C, Bhan AK. Role of appendix in the development of inflammatory bowel disease in TCR-α mutant mice. J Exp Med 1996;184:707-715.
250. 250. Dunkley ML, Husband AJ. The role of non-B cells in localizing an IgA plasma cell response in the intestine. Reg Immunol 1990-91;3:336-340.
251. 251. McDermott MR, Bienenstock J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol 1979;122:1892-1898.
252. 252. Sminia T, van der Brugge-Gamelkoorn GJ, Jeurissen SH. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit Rev Immunol 1989;9:119-150.
253. 253. VanCott JL, Brim TA, Lunney JK, Saif LJ. Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J Immunol 1994;152:3980-3990.
254. 254. Nadal D, Albini B, Chen CY, Schläpfer E, Bernstein JM, Ogra PL. Distribution and engraftment patterns of human tonsillar mononuclear cells and immunoglobulin-secreting cells in mice with severe combined immunodeficiency: role of the Epstein-Barr virus. Int Arch Allergy Appl Immunol 1991;95:341-351.
255. 255. Perry LL, Feilzer K, Portis JL, Caldwell HD. Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice. J Immunol 1998;160:2905-2914.
256. 256. Picker LJ, et al. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol 1994;24:1269-1277.
257. 257. Wagner N, et al. Critical role for β7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996;382:366-370.
258. 258. Abitorabi MA, Mackay CR, Jerome EH, Osorio O, Butcher EC, Erle DJ. Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph. J Immunol 1996;156:3111-3117.
259. 259. Quiding-Järbrink M, Granstrom G, Nordström I, Holmgren J, Czerkinsky C. Induction of compartmentalized B-cell responses in human tonsils. Infect Immun 1995;63:853-857.
260. 260. Balmelli C, Roden R, Potts A, Schiller J, De Grandi P, Nardelli-Haefliger D. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J Virol 1998;72:8220-8229.
261. 261. Hordnes K, Tynning T, Kvam AI, Jonsson R, Haneberg B. Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women. Infect Immun 1996;64:1643-1652.
262. 262. Crowley-Nowick PA, et al. Rectal immunization for induction of specific antibody in the genital tract of women. J Clin Immunol 1997;17:370-379.
263. 263. Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 1997;65:1387-1394.
264. 264. Bentley AM, et al. Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J Allergy Clin Immunol 1993;92:857-868.
265. 265. Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Molec Biol 1995;12:624-632.
266. 266. Norderhaug IN, Johansen F-E, Schjerven H, Brandtzaeg P. Regulation of the formation and epithelial transport of secretory immunoglobulins. Crit Rev Immunol (In press).
267. 267. Brandtzaeg P. Polymeric IgA is complexed with secretory component (SC) on the surface of human intestinal epithelial cells. Scand J Immunol 1978;8:39-52.
268. 268. Mostov KE, Blobel G. A transmembrane precursor of secretory component. The receptor for transcellular transport of polymeric immunoglobulins. J Biol Chem 1982;157:11816-11821.
269. 269. Brandtzaeg P. Immunohistochemical studies on various aspects of glandular immunoglobulin transport in man. Histochem J 1977;9:553-572.
270. 270. Brandtzaeg P, Baklien K. Intestinal secretion of IgA and IgM: a hypothetical model. Ciba Found Symp 1977;46:77-108.
271. 271. Valnes K, Brandtzaeg P, Elgjo K, Stave R. Specific and nonspecific humoral defense factors in the epithelium of normal and inflamed gastric mucosa. Immunohistochemical localization of immunoglobulins, secretory component, lysozyme, and lactoferrin. Gastroenterology 1984;86:402-412.
272. 272. Røe M, Norderhaug IN, Brandtzaeg P, Johansen F-E. Fine-specificity of ligand-binding domain 1 in the polymeric immunoglobulin receptor: importance of the CDR2-containing region for IgM interaction. J Immunol 1999;162:6046-6052.
273. 273. Norderhaug IN, Johansen F-E, Krajči P, Brandtzaeg P. Domain deletions in the human polymeric Ig receptor disclose differences between its dimeric IgA and pentameric IgM interaction. Eur J Immunol (In press).
274. 274. Conley ME, Delacroix DL. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann Intern Med 1987;106:892-899.
275. 275. Lindh E. Increased risistance of immunoglobulin A dimers to proteolytic degradation after binding of secretory component. J Immunol 1975;114:284-286.
276. 276. Crottet P, Corthesy B. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab′)2: a possible implication for mucosal defense. J Immunol 1998;161:5445-5453.
277. 277. Berdoz J, Blanc CT, Reinhardt M, Kraehenbuhl JP, Corthesy B. In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc Natl Acad Sci USA 1999;96:3029-3034.
278. 278. Brandtzaeg P. Structure, synthesis and external transfer of mucosal immunoglobulins. Ann Inst Pasteur Immunol 1973;124C: 417-438.
279. 279. Prigent-Delecourt L, Coffin B, Colombel JF, Dehennin JP, Vaerman JP, Rambaud JC. Secretion of immunoglobulins and plasma proteins from the colonic mucosa: an in vivo study in man. Clin Exp Immunol 1995;99:221-225.
280. 280. Gitlin D, Sasaki T. Immunoglobulins G, A, and M determined in single cells from human tonsil. Science 1969;164:1532-1534.
281. 281. Alberini CM, Bet P, Milstein C, Sitia R. Secretion of immunoglobulin M assembly intermediates in the presence of reducing agents. Nature 1990;347:485-487.
282. 282. Natvig IB, Johansen F-E, Nordeng TW, Haraldsen G, Brandtzaeg P. Mechanism for enhanced external transfer of dimeric IgA over pentameric IgM. Studies of diffusion, binding to the human polymeric Ig receptor, and epithelial transcytosis. J Immunol 1997;159:4330-4340.
283. 283. Song W, Bomsel M, Casanova J, Vaerman JP, Mostov K. Stimulation of transcytosis of the polymeric immunoglobulin receptor by dimeric IgA. Proc Natl Acad Sci USA 1994;91:163-166.
284. 284. Song W, Vaerman JP, Mostov KE. Dimeric and tetrameric IgA are transcytosed equally by the polymeric Ig receptor. J Immunol 1995;155:715-721.
285. 285. Giffroy D, et al. In vivo stimulation of polymeric Ig receptor transcytosis by circulating polymeric IgA in rat liver. Int Immunol 1998;10:347-354.
286. 286. Nagura H, Nakane PK, Brown WR. Secretory component in immunoglobulin deficiency and immunoelectron microscopic study of intestinal epithelium. Scand J Immunol 1980;12:359-363.
287. 287. Portis JL, Coe JE. IgM the secretory immunoglobulin of reptiles and amphibians. Nature 1975;258:547-548.
288. 288. St. Louis-Cormier EA, Osterland CK, Anderson PD. Evidence for a cutaneous secretory immune system in rainbow trout (Salmo gairdneri). Dev Comp Immunol 1984;8:71-80.
289. 289. Mansikka A. Chicken IgA H chains. Implications concerning the evolution of H chain genes. J Immunol 1992;149:855-861.
290. 290. Renegar KB, Jackson GD, Mestecky J. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol 1998;160:1219-1223.
291. 291. Ma JK, et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 1998;4:601-606.
292. 292. Russell MW, Reinholdt J, Kilian M. Anti-inflammatory activity of human IgA antibodies and their Fab α fragments: inhibition of IgG-mediated complement activation. Eur J Immunol 1989;19:2243-2249.
293. 293. Phillips JO, Everson MP, Moldoveanu Z, Lue C, Mestecky J. Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol 1990;145:1740-1744.
294. 294. Denning GM. IL-4 and IFN-γ synergistically increase total polymeric IgA receptor levels in human intestinal epithelial cells. Role of protein tyrosine-kinases. J Immunol 1996;156:4807-4814.
295. 295. Kvale D, Brandtzaeg P. Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29. Gut 1995;36:737-742.
296. 296. Hayashi M, et al. The polymeric immunoglobulin receptor (secretory component) in a human intestinal epithelial cell line is up-regulated by interleukin-1. Immunology 1997;92:220-225.
297. 297. Nilsen EM, Johansen F-E, Kvale D, Kraj-i P, Brandtzaeg P. Different regulatory pathways employed in cytokine-enhanced expression of secretory component and epithelial HLA class I genes. Eur J Immunol 1999;29:168-179.
298. 298. Krajči P, Kvale D, Taskén K, Brandtzaeg P. Molecular cloning and exon-intron mapping of the gene encoding human transmembrane secretory component (the poly-Ig receptor). Eur J Immunol 1992;22:2309-2315.
299. 299. Verrijdt G, Swinnen J, Peeters B, Verhoeven G, Rombauts W, Claessens F. Characterization of the human secretory component gene promoter. Biochim Biophys Acta 1997;1350:147-154.
300. 300. Johansen F-E, Bosløven B, Krajči P, Brandtzaeg P. A composite DNA element in the promoter of the polymeric immunoglobulin receptor promoter regulates its constitutive expression. Eur J Immunol 1998;28:1161-1171.
301. 301. Piskurich JF, et al. Transcriptional regulation of the human polymeric immunoglobulin receptor gene by interferon-γ. Mol Immunol 1997;34:75-91.
302. 302. Kaetzel CS, Blanch VJ, Hempen PM, Phillips KM, Piskurich JF, Youngman KR. The polymeric immunoglobulin receptor: structure and synthesis. Biochem Soc Trans 1997;25:475-480.
303. 303. Martin MG. Characterization of the 5′-flanking region of the murine polymeric IgA receptor gene. Am J Physiol 1998;275: G778-G788.
304. 304. Blanch VJ, Piskurich JF, Kaetzel CS. Cutting edge: coordinate regulation of IFN regulatory factor-1 and the polymeric Ig receptor by proinflammatory cytokines. J Immunol 1999;162:1232-1235.
305. 305. Schjerven H, Nilsen EM, Brandtzaeg P, Johansen F-E. IL-4 and TNF-α enhance the expression of human pIg-receptor through DNA dements in the first intron. 29th Ann. Meeting of SSI, Abstract 36. Scand J Immunol 1998;47:623.
306. 306. Brandtzaeg P, Halstensen TS, Huitfeldt HS, Krajči K, Kvale D, Scott H, Thrane PS. Epithelial expression of HLA, secretory component (poly-Ig receptor), and adhesion molecules in the human alimentary tract. Ann N Y Acad Sci 1992;664:157-179.
307. 307. Brandtzaeg P, Baklien K. Characterization of the IgA-immunocyte population and its product in a patient with excessive intestinal formation of IgA. Clin Exp Immunol 1977;30:77-88.
308. 308. Hocini H, et al. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res Hum Retroviruses 1997;13:1179-1185.
309. 309. Mazzoli S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997;3:1250-1257.
310. 310. Porter P, Linggood MA. Novel mucosal anti-microbial functions interfering with the plasmid-mediated virulence determinants of adherence and drug resistance. Am N Y Acad Sci 1983;409:564-578.
311. 311. Brandtzaeg P. Development of the mucosal immune system in humans. In: Bindels JG, Goedhart AC, Visser HKA, eds. Recent developments in infant nutrition. London: Kluwer Academic Publishers; 1996. p. 349-376.
312. 312. Quan CP, Berneman A, Pires R, Avrameas S, Bouvet JP. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 1997;65:3997-4004.
313. 313. Bouvet JP, Dighiero G. From natural polyreactive autoantibodies to á la carte monoreactive antibodies to infectious agents: is it a small world after all? Infect Immun 1998;66:1-4.
314. 314. Bouvet J-P, Pirès R, Quan CP. Protein Fv (Fv fragment binding protein): a mucosal human superantigen reacting with normal immunoglobulins. In: Zouali M, ed. Human B-cell superantigens. Austin: RG Landes; 1996. p. 179-187.
315. 315. Giugliano LG, Ribeiro STG, Vainstein MH, Ulhoa CJ. Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli. J Med Microbiol 1995;42:3-9.
316. 316. Dallas SD, Rolfe RD. Binding of Clostridium difficile toxin A to human milt secretory component. J Med Microbiol 1998;47:879-888.
317. 317. Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol 1997;25:1113-1124.
318. 318. Brandtzaeg P, Tolo K. Mucosal penetrability enhanced by serum-derived antibodies. Nature 1977;266:262-263.
319. 319. Paganelli R, Levinsky RJ. Solid phase radioimmunoassay for detection of circulating food protein antigens in human serum. J Immunol Methods 1980;37:333-341.
320. 320. Kilshaw PJ, Cant AJ. The passage of maternal dietary proteins into human breast milk. Int Arch Allergy Appl Immunol 1984;75:8-15.
321. 321. Husby S. Jensenius JC, Svehag S-E. Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scand J Immunol 1985;22:83-92.
322. 322. Sanderson IR, Walker WA. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 1993;104:622-639.
323. 323. Morton HC, van Zandbergen G, van Kooten C, Howard CJ, van de Winkel JGJ, Brandtzaeg P. Immunoglobulin-binding sites of human FcRI (CD89) and bovine Fc2R are located in their membrane-distal extracellular domains. J Exp Med 1999;189:1715-1722.
324. 324. Wolf HM, Fischer MB, Pühringer H, Samstag A, Vogel E, Eibl MM. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-α, interleukin-6) in human monocytes. Blood 1994;83:1278-1288.
325. 325. Wolf HM, Vogel E, Fischer MB, Rengs H, Schwarz H-P, Eibl MM. Inhibition of receptor-dependent and receptor-independent generation of the respiratory burst in human neutrophils and monocytes by human serum IgA. Pediatr Res 1994;36:235-243.
326. 326. Devière J, et al. IgA triggers tumor necrosis factor α secretion by monocytes: a study in normal subjects and patients with alcoholic cirrhosis. Hepatology 1991;13:670-675.
327. 327. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-2400.
328. 328. Taylor B, Norman AP, Orgel HA, Stokes CR, Turner MW, Soothill JF. Transient IgA deficiency and pathogenesis of infantile atopy. Lancet 1973;2:111-113.
329. 329. Soothill JF. Some intrinsic and extrinsic factors predisposing to allergy. Proc R Soc Med 1976;69:439-442.
330. 330. Sloper KS, Brook CG, Kingston D, Pearson JR, Shiner M. Eczema and atopy in early childhood: low IgA plasma cell counts in the jejunal mucosa. Arch Dis Child 1981;56:939-942.
331. 331. Perkkiö M. Immunohistochemical study of intestinal biopsies from children with atopic eczema due to food allergy. Allergy 1980;35:573-580.
332. 331. Van Asperen PP, et al. The relationship between atopy and salivary IgA deficiency in infancy. Clin Exp Immunol 1985;62:753-757.
333. 333. Kilian M, Husby S, Host A, Halken S. Increased proportions of bacteria capable of cleaving IgA1 in the pharynx of infants with atopic disease. Pediatr Res 1995;38:182-186.
334. 334. Lamkhioued B, Gounni AS, Gruart V, Pierce A, Capron A, Capron M. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur J Immunol 1995;25:117-125.
335. 335. Motegi Y, Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J Immunol 1998;161:4340-4346.
336. 336. Peebles RS Jr, Liu MC, Adkinson NF Jr, Lichtenstein LM, Hamilton RG. Ragweed-specific antibodies in bronchoalveolar lavage fluids and serum before and after segmental lung challenge: IgE and IgA associated with eosinophil degranulation. J Allergy Clin Immunol 1998;101:265-73.
337. 337. Iikura M, et al. Secretory IgA induces degranulation of IL-3-primed basophils. J Immunol 1998;161:1510-1515.
338. 338. Brandtzaeg P, Halstensen TS, Hvatum M, Kvale D, Scott H. The serologic and mucosal immunologic basis of celiac disease. In: Walker WA, Harmatz PR, Wershil BK, eds. Immunophysiology of the gut. Bristol-Myers Squibb/Mead Johnson Nutrition Symposia. Vol 11. London: Academic Press; 1993, p. 295-333.
339. 339. Berin MC, Kiliaan AJ, Yang PC, Groot JA, Taminiau JA, Perdue MH. Rapid transepithelial antigen transport in rat jejunum: impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997;113:856-864.
340. 340. Lim PL, Rowley D. The effect of antibody on the intestinal absorption of macromolecules and on intestinal permeability in adult mice. Int Arch Allergy Appl Immunol 1982;68:41-46.
341. 341. Sutton BJ, Gould HJ. The human IgE network. Nature 1993;366:421-428.
342. 342. Mamula MJ, Janeway CA. Do B cells drive the diversification of immune responses? Immunol Today 1993;14:151-152.
343. 343. Eynon EE, Parker DC. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 1992;175:131-138.
344. 344. Pistoia V. Production of cytokines by human B cells in health and disease. Immunol Today 1997;18:343-350.
345. + T cells in the normal gut mucosa. J Immunol 1998;160:754-762.
346. 346. Kim P-H, Eckmann L, Lee WJ, Han W, Kagnoff MF. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-β1. J Immunol 1998;160:1198-1203.
347. 347. Soltoft J, Söeberg B. Immunoglobulin-containing cells in the small intestine during acute enteritis. Gut 1972;13:535-538.
348. 348. Agus SG, Falchuk ZM, Sessoms CS, Wyatt RG, Dolin R. Increased jejunal IgA synthesis in vitro during acute infectious non-bacterial gastroenteritis. Am J Dig Dis 1974;19:127-131.
349. 349. Silbart LK, Keren DF. Reduction of intestinal carcinogen absorption by carcinogen-specific secretory immunity. Science 1989;243:1462-1464.
350. 350. Rasmussen MV, Silbart LK. Preoral administration of specific antibody enhances carcinogen excretion. Immunotherapy 1998;21:418-426.